Email bulletins

Archive

May 2021

  • WHO says 2030 hepatitis elimination targets will not be met without massive scale-up of testing and treatment
  • Developing global health sector strategies on HIV, viral hepatitis and sexually transmitted infections for 2022-2030
  • COVID-19 reduced US hepatitis C testing, diagnosis and treatment
  • Liver function improves in most people with cirrhosis after hepatitis C cure
  • Australia: recent drug users more likely to start hepatitis C treatment
  • New report shows discriminatory sobriety restrictions undermine public health efforts to eliminate hepatitis C
  • Is this your copy of the infohep news bulletin?

April 2021

  • Screen for hepatitis C while vaccinating for COVID-19, say Spanish experts
  • Hepatitis C testing in gay and bisexual men with HIV below target, US study finds
  • Swiss opioid substitution therapy programme reports strong progress towards hepatitis C elimination
  • Community-wide hepatitis C elimination campaign in Seattle increases number treated tenfold
  • Reinfection after hepatitis C cure predicted by sexually transmitted infections
  • HepB Global Community: a global online forum supporting people affected by hepatitis B
  • Is this your copy of the infohep news bulletin?

March 2021

  • 12 good practices that should be part of the hepatitis C standard of care
  • People with HIV and hepatitis B should have ongoing monitoring for liver cancer
  • Pancreatic and colorectal cancer risk raised in people with hepatitis C
  • Outreach to homeless in England achieved large-scale testing for hepatitis C during the COVID-19 lockdown
  • Catch up on the EASL Digital Liver Cancer Summit
  • Is this your copy of the infohep news bulletin?

February 2021

  • Hepatitis C does not raise the risk of death from COVID-19
  • COVID-19 slows viral hepatitis elimination, global survey finds
  • COVID-19 hits viral hepatitis care for vulnerable populations
  • Hepatitis C treatment reduces stroke and heart attack risk
  • Hepatitis C declining among drug users in UK
  • High adherence and hepatitis C cure rates in active drug and alcohol users
  • WHA releases new messaging guide for global fund advocates
  • Is this your copy of the infohep news bulletin?

January 2021

  • Will people with liver disease be prioritised for COVID-19 vaccination?
  • Questions about COVID-19 vaccination for people with liver disease: guidance from patient associations and health bodies
  • Public-sector hepatitis C treatment programmes expanding in lower- and middle-income countries
  • What's needed to eliminate hepatitis C in people with HIV in Scotland?
  • Hepatitis C elimination in France feasible if new infections in gay and bisexual men decline
  • HIV doubles the risk of liver fibrosis by middle age, without viral hepatitis
  • Launch of new international liver patients’ organisation: Liver Patients International
  • Catch up on the World Hepatitis Alliance webinar on hepatitis B diagnostics
  • Is this your copy of the infohep news bulletin?